SRL
KPRX icon

Scientech Research LLC’s Kiora Pharmaceuticals KPRX Stock Holding History

Scientech Research LLC’s Portfolio KPRX Stock Details KPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$49.3K Buy
+18,746
New +$47.1K 0.04% 197

Other funds holding KPRX

PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
HF
HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

Scientech Research LLC's KPRX Position: Q2 2026 in Review

Scientech Research LLC opened a new position in Kiora Pharmaceuticals (KPRX) in Q2 2026: 18,746 shares worth $49.3K. The stake represents 0.04% of the portfolio and ranks #197 among its holdings.

22 funds tracked by Wall St. Rank hold KPRX as of Q2 2026.

  • Scientech Research LLC held 18,746 shares of Kiora Pharmaceuticals worth $49.3K as of Q2 2026.
  • Kiora Pharmaceuticals was a new Scientech Research LLC position in Q2 2026.
  • Kiora Pharmaceuticals made up 0.04% of Scientech Research LLC's portfolio in Q2 2026, its #197 holding.
  • 22 funds tracked by Wall St. Rank held Kiora Pharmaceuticals as of Q2 2026.

Based on Scientech Research LLC's 13F filing for Q2 2026, filed 14 Aug 2026.